Contineum Therapeutics, Inc. (CTNM)
NASDAQ: CTNM · IEX Real-Time Price · USD
21.17
+1.02 (5.06%)
Jul 22, 2024, 2:23 PM EDT - Market open
Contineum Therapeutics Employees
Contineum Therapeutics had 31 employees as of December 31, 2023.
Employees
31
Change
n/a
Growth
n/a
Revenue / Employee
$1,612,903
Profits / Employee
-$14,419
Market Cap
547.91M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 31 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Community Health Systems | 61,000 |
| Cross Country Healthcare | 13,131 |
| Sharecare | 3,352 |
| GRAIL, LLC | 1,360 |
| Valneva SE | 676 |
| COMPASS Pathways | 186 |
| Y-mAbs Therapeutics | 100 |
| PureTech Health | 90 |
CTNM News
- 27 days ago - Contineum Therapeutics Announces Appointment of Sarah Boyce to Board of Directors - Business Wire
- 6 weeks ago - Contineum Therapeutics to Present at the 45th Annual Goldman Sachs Healthcare Conference - Business Wire
- 6 weeks ago - Contineum Therapeutics Announces Appointment of John Healy as General Counsel & Corporate Secretary - Business Wire
- 2 months ago - Contineum Therapeutics Announces Appointment of Troy Ignelzi to Board of Directors - Business Wire
- 2 months ago - Contineum Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights - Business Wire
- 3 months ago - Contineum Therapeutics Announces Pricing of Initial Public Offering - GlobeNewsWire
- 4 months ago - Neuroscience and inflammation biotech Contineum Therapeutics files for a $150 million IPO - Renaissance Capital
- 4 months ago - Contineum Therapeutics IPO Registration Document (S-1) - SEC